Summary: No direct pharmacological interaction exists between tirzepatide (Mounjaro/Zepbound) and cannabis, but concurrent use may undermine diabetes control and weight management goals through opposing effects on appetite and unpredictable impacts on blood glucose
The STEP program, which included over 4,500 participants, demonstrated that patients on semaglutide achieved average weight reductions of 14-15% over 68 weeks, compared to less than 3% in the placebo group
Wegovy and fertility: the key facts Wegovy is not known to directly impact fertility
Semaglutide lowered cardic events but enrollees weren't treated with currently available generic medications to achieve appropriate cholesterol, blood pressure, and inflammation goals Amongst all the meaningless observational studies grabbing media headlines in the last year and the constant noise and misinformation emanating from the nutraceutical industry and wellness industries it likely has been difficult for readers to note that a very important and potentially cardiology practice-changing randomized trial, the SELECT trial, was published a year ago
Dilokthornsakul, W., Dhippayom, T., & Dilokthornsakul, P
